Michigan State: Liver Disease Action Plan Aims to Improve Screening, Diagnosis and Treatment
October 12, 2021
October 12, 2021
EAST LANSING, Michigan, Oct. 12 (TNSJou) -- Michigan State University issued the following news on Oct. 11, 2021:
Liver disease isn't talked about as much as heart disease, diabetes and other common chronic illnesses. But "silent" conditions like nonalcoholic fatty liver disease and nonalcoholic steatohepatitis commonly affect those with type 2 diabetes and obesity, causing a rising burden in the U.S. and around the world.
Kim Pfotenhauer, director of cle . . .
Liver disease isn't talked about as much as heart disease, diabetes and other common chronic illnesses. But "silent" conditions like nonalcoholic fatty liver disease and nonalcoholic steatohepatitis commonly affect those with type 2 diabetes and obesity, causing a rising burden in the U.S. and around the world.
Kim Pfotenhauer, director of cle . . .